Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 35,5x - 39,3x | 37,4x |
| Selected Fwd Revenue Multiple | 37,2x - 41,1x | 39,1x |
| Fair Value | 77,81₺ - 86,01₺ | 81,91₺ |
| Upside | -24,8% - -16,9% | -20,9% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Consus Enerji Isletmeciligi ve Hizmetleri A.S. | CONSE | IBSE:CONSE |
| Kartal Yenilenebilir Enerji Uretim A.S. | KARYE | IBSE:KARYE |
| Biotrend Cevre ve Enerji Yatirimlari A.S. | BIOEN | IBSE:BIOEN |
| Zorlu Enerji Elektrik Üretim A.S. | ZOREN | IBSE:ZOREN |
| Aydem Yenilenebilir Enerji A.S. | AYDEM | IBSE:AYDEM |
| Pamukova Yenilenebilir Elektrik Uretim A.S. | PAMEL | IBSE:PAMEL |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| CONSE | KARYE | BIOEN | ZOREN | AYDEM | PAMEL | |||
| IBSE:CONSE | IBSE:KARYE | IBSE:BIOEN | IBSE:ZOREN | IBSE:AYDEM | IBSE:PAMEL | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | NM- | 58.1% | 96.4% | 29.3% | 40.6% | 54.0% | ||
| 3Y CAGR | 54.4% | 63.3% | 84.5% | 36.6% | 74.4% | 93.4% | ||
| Latest Twelve Months | -19.7% | 48.2% | -16.6% | -24.7% | -28.3% | -15.1% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | -3.3% | 41.3% | 10.7% | 11.2% | 42.8% | 169.3% | ||
| Prior Fiscal Year | -20.0% | 18.3% | 1.9% | 6.3% | 32.4% | 202.2% | ||
| Latest Fiscal Year | 4.2% | 39.3% | -13.7% | 3.9% | 15.3% | 109.8% | ||
| Latest Twelve Months | 4.2% | 39.3% | -13.7% | 3.9% | 15.3% | 109.8% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 2.97x | 5.19x | 4.96x | 1.86x | 5.10x | 48.33x | ||
| EV / LTM EBIT | 71.0x | 13.2x | -36.3x | 47.3x | 33.4x | 44.0x | ||
| Price / LTM Sales | 1.54x | 3.92x | 3.64x | 0.56x | 1.79x | 48.29x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 1.86x | 4.96x | 5.19x | |||||
| Historical EV / LTM Revenue | 39.90x | 53.34x | 302.54x | |||||
| Selected EV / LTM Revenue | 35.54x | 37.41x | 39.28x | |||||
| (x) LTM Revenue | 67 | 67 | 67 | |||||
| (=) Implied Enterprise Value | 2,368 | 2,493 | 2,618 | |||||
| (-) Non-shareholder Claims * | (3) | (3) | (3) | |||||
| (=) Equity Value | 2,366 | 2,490 | 2,615 | |||||
| (/) Shares Outstanding | 31.1 | 31.1 | 31.1 | |||||
| Implied Value Range | 76.07 | 80.08 | 84.09 | |||||
| FX Rate: TRY/TRY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 76.07 | 80.08 | 84.09 | 103.50 | ||||
| Upside / (Downside) | -26.5% | -22.6% | -18.8% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | CONSE | KARYE | BIOEN | ZOREN | AYDEM | PAMEL | |
| Enterprise Value | 4,065 | 2,010 | 13,330 | 55,186 | 33,558 | 3,221 | |
| (+) Cash & Short Term Investments | 27 | 55 | 99 | 1,542 | 2,603 | 2 | |
| (+) Investments & Other | 0 | 0 | 319 | 5,752 | 0 | 0 | |
| (-) Debt | (1,979) | (546) | (3,953) | (45,729) | (24,371) | (4) | |
| (-) Other Liabilities | 0 | 0 | (10) | (0) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 2,113 | 1,519 | 9,785 | 16,750 | 11,790 | 3,218 | |
| (/) Shares Outstanding | 771.0 | 55.0 | 500.0 | 5,000.0 | 698.9 | 31.1 | |
| Implied Stock Price | 2.74 | 27.62 | 19.57 | 3.35 | 16.87 | 103.50 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2.74 | 27.62 | 19.57 | 3.35 | 16.87 | 103.50 | |
| Trading Currency | TRY | TRY | TRY | TRY | TRY | TRY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |